Sort
50,496 grants matching “lung cancer”
Exposure and biological response biomarkers of cigarette smoke
$549,700Ian Alexander Blair · University Of Pennsylvania · U01 · FY2008 · ES
Using CBPR to Implement Smoking Cessation in an Urban American Indian Community
$549,640Christine Makosky Daley · University Of Kansas Medical Center · R24 · FY2010 · MD
Administrative Core
$549,616Joseph Vincent Bonventre · Brigham And Women'S Hospital · U2C · FY2025 · DK
Preclinical Evaluation of Medications to Treat Polydrug Addiction
$549,606Nancy K. Mello · Mclean Hospital · R01 · FY2011 · DA
Longitudinal Spatial-Nonspatial Decision Support for Competing Outcomes in Head and Neck Cancer Therapy
$549,602Georgeta-Elisabeta Marai · University Of Illinois At Chicago · R01 · FY2025 · CA
Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity
$549,598David G Denardo · Washington University · R01 · FY2023 · CA
Multilevel Determinants of Differences in Lung Cancer Screening Utilization
$549,580Lori Sakoda · Kaiser Foundation Research Institute · R01 · FY2025 · CA
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
$549,575Seyedabdollah Mirbozorgi · University Of Alabama At Birmingham · · FY2024 · ENG
Quantifying and Characterizing the shared genetic contribution to common cancers
$549,469Sara Lindstroem · University Of Washington · U01 · FY2019 · CA
Southern Nevada Cancer Research Foundation--CCOP
$549,418Southern Nevada Cancer Research Fdn · U10 · FY2003 · CA
Using CBPR to Implement Smoking Cessation in an Urban American Indian Community
$549,372Christine Makosky Daley · University Of Kansas Medical Center · R24 · FY2011 · MD
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer
$549,366Jae-Wook Jeong · University Of Missouri-Columbia · R01 · FY2025 · CA
Multiparameter single-cell genomics platform for personalized treatment of cancer
$549,310Eric Brouzes · State University New York Stony Brook · R01 · FY2016 · CA
Molecular and cellular mechanism of IL-17 signaling in tumorigenesis
$549,214Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · P01 · FY2016 · CA
Molecular features impacting drug resistance in atypical EGFR exon 18 and exon 20 mutant non-small cell lung cancers and the development of novel mutant-selective inhibitors
$549,195John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Faith Moves Mountains: A CBPR Appalachian Wellness & Cancer Prevention Program
$549,129Nancy E Schoenberg · University Of Kentucky · R24 · FY2012 · MD
Tumor-Specific Fluorescent Cocktail Enables Image-Guided Cytoreductive Surgery
$549,126Sumith Kularatne · On Target Laboratories, Llc · R44 · FY2018 · CA
High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers
$549,080Henning Willers · Massachusetts General Hospital · U01 · FY2019 · CA
Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity
$549,025David G Denardo · Washington University · R01 · FY2021 · CA
Interrogating a novel axis of tumor suppression in small cell lung cancer
$548,915David Macpherson · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinoma
$548,908Adam I Marcus · Emory University · P01 · FY2022 · CA
The tumor ecosystem in cancer progression and immunotherapeutic response
$548,896Alexander Y. Rudensky · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA
Modeling the SCLC Phenotypic Space
$548,781Vito Quaranta · Vanderbilt University · U54 · FY2020 · CA
Developing new therapeutic strategies for brain metastasis
$548,753Eva Hernando · New York University School Of Medicine · R01 · FY2025 · CA
Deciphering the molecular control of intratumoral dendritic cells
$548,745Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA